FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydroxychloroquine Sulfate Tablets
Status: Discontinuation
»Therapeutic Categories: Anti-Infective; Rheumatology

Teva Pharmaceuticals (New 12/07/2020)

Company Contact Information:

Presentation Posting Date Related Information
200 mg, 500 count bottle (NDC 0591-3041-05) 12/07/2020 Teva made a business decision to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English